Mineralocorticoid receptor signalling in primary aldosteronism.
adrenal cortex
aldosterone
cortisol
mineralocorticoid receptor
primary aldosteronism
Journal
The Journal of endocrinology
ISSN: 1479-6805
Titre abrégé: J Endocrinol
Pays: England
ID NLM: 0375363
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
received:
07
10
2022
accepted:
24
07
2023
medline:
31
8
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
Primary aldosteronism, or Conn syndrome, is the most common endocrine cause of hypertension. It is associated with a higher risk of cardiovascular, metabolic and renal diseases, as well as a lower quality of life than for hypertension due to other causes. The multi-systemic effects of primary aldosteronism can be attributed to aldosterone-mediated activation of the mineralocorticoid receptor in a range of tissues. In this review, we explore the signalling pathways of the mineralocorticoid receptor, with a shift from the traditional focus on the regulation of renal sodium-potassium exchange to a broader understanding of its role in the modulation of tissue inflammation, fibrosis and remodelling. The appreciation of primary aldosteronism as a multi-system disease with tissue-specific pathophysiology may lead to more vigilant testing and earlier institution of targeted interventions.
Identifiants
pubmed: 37486000
doi: 10.1530/JOE-22-0249
pii: e220249
doi:
pii:
Substances chimiques
Receptors, Mineralocorticoid
0
Mineralocorticoid Receptor Antagonists
0
Aldosterone
4964P6T9RB
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM